Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 27th March 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 9, 2018
Previous Article Next Article

β-lactam/β-lactamase inhibitor combinations: an update

Author affiliations

Abstract

Antibiotic resistance caused by β-lactamase production continues to present a growing challenge to the efficacy of β-lactams and their role as the most important class of clinically used antibiotics. In response to this threat however, only a handful of β-lactamase inhibitors have been introduced to the market over the past thirty years. The first-generation β-lactamase inhibitors (clavulanic acid, sulbactam and tazobactam) are all β-lactam derivatives and work primarily by inactivating class A and some class C serine β-lactamases. The newer generations of β-lactamase inhibitors including avibactam and vaborbactam are based on non-β-lactam structures and their spectrum of inhibition is extended to KPC as an important class A carbapenemase. Despite these advances several class D and virtually all important class B β-lactamases are resistant to existing inhibitors. The present review provides an overview of recent FDA-approved β-lactam/β-lactamase inhibitor combinations as well as an update on research efforts aimed at the discovery and development of novel β-lactamase inhibitors.

Graphical abstract: β-lactam/β-lactamase inhibitor combinations: an update

Back to tab navigation

Publication details

The article was received on 08 Jul 2018, accepted on 16 Aug 2018 and first published on 17 Aug 2018


Article type: Review Article
DOI: 10.1039/C8MD00342D
Citation: Med. Chem. Commun., 2018,9, 1439-1456

  •   Request permissions

    β-lactam/β-lactamase inhibitor combinations: an update

    K. H. M. E. Tehrani and N. I. Martin, Med. Chem. Commun., 2018, 9, 1439
    DOI: 10.1039/C8MD00342D

Search articles by author

Spotlight

Advertisements